Oncology Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q2 | 65.5% | 1.096 | Q2 | 86.1% |
| 2024 | 5.2 | Q1 | 80.7% | 0.968 | Q2 | 83.3% |
| 2023 | 3.1 | Q2 | 54.4% | 0.747 | Q2 | 77.6% |
| 2022 | 3.6 | 54.5% | 0.861 | Q2 | 82.5% | |
| 2021 | — | 25.2% | 0.737 | Q2 | 78.9% | |
| 2020 | — | — | 1.637 | Q1 | 93.5% | |
| 2019 | — | — | 1.703 | Q1 | 94.1% | |
| 2018 | — | — | 1.257 | Q2 | 88.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1970-5565
ISSN
1970-5557
region
Western Europe
coverage
2007-2026